| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3922 | 1998 |
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability A Umar, CR Boland, JP Terdiman, S Syngal, A Chapelle, J Rüschoff, ... Journal of the National Cancer Institute 96 (4), 261-268, 2004 | 3864 | 2004 |
| New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC HFA Vasen, P Watson, JP Mecklin, HT Lynch Gastroenterology 116 (6), 1453-1456, 1999 | 3236 | 1999 |
| The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC) HFA Vasen, JP Mecklin, PM Khan, HT Lynch Diseases of the Colon & Rectum 34 (5), 424-425, 1991 | 2675 | 1991 |
| Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ... The Lancet 378 (9809), 2081-2087, 2011 | 1145 | 2011 |
| Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis HF Vasen, JT Wijnen, FH Menko, JH Kleibeuker, BG Taal, G Griffioen, ... Gastroenterology 110 (4), 1020-1027, 1996 | 1077 | 1996 |
| Peutz–Jeghers syndrome: a systematic review and recommendations for management AD Beggs, AR Latchford, HFA Vasen, G Moslein, A Alonso, S Aretz, ... Gut 59 (7), 975-986, 2010 | 984 | 2010 |
| Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ... Gut 62 (6), 812-823, 2013 | 856 | 2013 |
| International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer MI Canto, F Harinck, RH Hruban, GJ Offerhaus, JW Poley, I Kamel, Y Nio, ... Gut 62 (3), 339-347, 2013 | 856 | 2013 |
| Guidelines for the clinical management of familial adenomatous polyposis (FAP) HFA Vasen, G Moeslein, A Alonso, S Aretz, I Bernstein, L Bertario, ... Gut 57 (5), 704-713, 2008 | 849 | 2008 |
| Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary … P Peltomaki, HF Vasen Gastroenterology 113 (4), 1146-1158, 1997 | 842 | 1997 |
| Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) HFA Vasen, G Möslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, ... Journal of medical genetics 44 (6), 353-362, 2007 | 768 | 2007 |
| The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome P Watson, HFA Vasen, JP Mecklin, I Bernstein, M Aarnio, HJ Järvinen, ... International journal of cancer 123 (2), 444-449, 2008 | 724 | 2008 |
| Mutations associated with HNPCC predisposition--Update of ICG-HNPCC/INSiGHT mutation database P Peltomäki, H Vasen Disease markers 20 (4-5), 269-276, 2004 | 583 | 2004 |
| Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 67 (7), 1306-1316, 2018 | 572 | 2018 |
| Duodenal adenomatosis in familial adenomatous polyposis S Bülow, J Björk, IJ Christensen, O Fausa, H Järvinen, F Moesgaard, ... Journal of Medical Genetics 41 (5), 341-341, 2004 | 570* | 2004 |
| Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases MR Stratton The Lancet 349 (9064), 1505-1510, 1997 | 570 | 1997 |
| Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (3), 464-472, 2017 | 562 | 2017 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020 | 535 | 2020 |
| Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) HFA Vasen, NA Gruis, RR Frants, PA van Der Velden, ETM Hille, ... International journal of cancer 87 (6), 809-811, 2000 | 522 | 2000 |
Frederic H MenkoConsultant Clinical Geneticist, Antoni van Leeuwenhoek Hospital/ Netherlands Cancer Institute在 nki.nl 的电子邮件经过验证
